Essential systemic anti-infectives and critical care active ingredients aligned with Saudi Food and Drug Authority (SFDA) quality parameters.
An in-depth analysis of supply chain resilience, regulatory dynamics, and localized manufacturing integration for active pharmaceutical ingredients across the Kingdom.
The Kingdom of Saudi Arabia (KSA) is undergoing an unprecedented healthcare and industrial transformation under the banner of Saudi Vision 2030. Central to this vision is the National Industrial Development and Logistics Program (NIDLP) and the Ministry of Health's mandate to localize pharmaceutical production. Historically dependent on finished dosage form (FDF) imports, Saudi Arabia is actively pivoting toward domestic pharmaceutical manufacturing, driving unprecedented regional demand for high-purity Active Pharmaceutical Ingredients (APIs), key building blocks, and customized peptide raw materials.
Key Industry Insight: The Saudi Arabian pharmaceutical market is projected to surpass USD 12 Billion in the coming years. Securing robust, cGMP-certified API supply lines compliant with Saudi Food and Drug Authority (SFDA) guidelines is the paramount operational imperative for drug manufacturers in Riyadh, Jeddah, Dammam, and King Abdullah Economic City (KAEC).
Global API procurement faces multifaceted challenges, ranging from raw material price volatility and geopolitically fragile transport routes to stringent environmental mandates. For pharmaceutical entities operating within Saudi Arabia, these global macro-trends manifest in specific supply chain requirements:
Modern therapy regimens in metabolic health, oncology, and systemic infectious diseases rely heavily on complex peptides and specialty molecules. Gentolex's manufacturing footprint incorporates state-of-the-art Solid-Phase Peptide Synthesis (SPPS), Liquid-Phase Peptide Synthesis (LPPS), and hybrid technology to deliver exceptional quality.
By implementing rigorous Process Analytical Technology (PAT) and real-time high-performance liquid chromatography (HPLC) purification cascades, we achieve purity metrics exceeding 99.5% for demanding protected amino acid derivatives, such as Fmoc-His(Trt)-Aib-Glu(OtBu)-Gly-OH and Ste-γ-Glu-AEEA-AEEA-OSU—vital building blocks for next-generation metabolic therapeutics and GLP-1 analogs targeted for the regional burden of metabolic conditions.
Integrating global raw material sourcing, cGMP technology transfer, and laboratory setup consultation for the Saudi healthcare sector.
Commercial and clinical scale supply of active pharmaceutical ingredients under strict cGMP protocols, fully supported by CEP, DMF, and SFDA-compliant dossier documentation.
Tailored synthesis of complex peptides, lipopeptides, and modified amino acid derivatives from milligram research quantities to multi-kilogram commercial production batches.
Finished Dosage Form (FDF) out-licensing opportunities complete with full bioequivalence studies, stability data under Zone IVb conditions, and validation documentation.
Turnkey engineering consultation for domestic Saudi plants aiming to establish advanced API synthesis suites, QA/QC analytical laboratories, and cleanroom facilities.
Streamlined centralized procurement for local formulation companies, mitigating complex international supply chain touchpoints and ensuring regulatory oversight.
Dedicated regulatory specialists supporting local market registration, SFDA filing queries, stability study execution, and analytical method validation (AMV).
Explore our comprehensive portfolio of cGMP pharmaceutical ingredients, peptide raw materials, and high-purity synthetic intermediates.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.
Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions. Our overall factory construction area of 250,000 square meters under international cGMP standards offers flexible, scalable and cost-effective solutions for the Saudi Arabian market.
Latest updates on peptide synthesis innovations, therapeutic research grade active ingredients, and clinical developments.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient (API) composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP)...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and pharmaceutical research organizations...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair and inflammatory regulation...
View Details
With the continuous development of neuroscience, peptide technology, and life science research, neuroactive peptides have become an important area of scientific investigation...
View Details
SS-31 API, also known as Elamipretide, MTP-131, Bendavia, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane...
View DetailsAddressing regulatory dossiers, cold-chain compliance, SFDA approval processes, and API batch scalability.
We supply complete documentation packages tailored for Saudi Food and Drug Authority (SFDA) submission. This includes Open and Closed parts of the Drug Master File (DMF) in eCTD format, Certificates of Analysis (CoA), stability data under ICH Climate Zone IVb conditions (30°C/75% RH), residual solvent validation per ICH Q3C, and GMP certificates issued by accredited regulatory authorities.
Our critical care systemic anti-infectives (Caspofungin, Daptomycin, Micafungin, Vancomycin) are manufactured in strict compliance with cGMP guidelines. Every batch undergoes rigorous quality control using HPLC, LC-MS, Bacterial Endotoxin (LAL) testing, bio-burden testing, and residual solvent quantification to guarantee high purity and minimal batch-to-batch variation for clinical safety.
Yes. Gentolex specializes in custom peptide synthesis ranging from advanced building blocks (such as Fmoc-His-Aib-OH and Ste-γ-Glu-AEEA-AEEA-OSU) to complex custom sequences. We support Saudi research laboratories and full-scale commercial manufacturing facilities with scalable synthesis capabilities from grams to multi-kilograms.
We maintain structured logistics channels targeting major logistics hubs in Saudi Arabia, including King Khalid International Airport (Riyadh), King Abdulaziz International Airport (Jeddah), and King Fahd International Airport (Dammam). Temperature-sensitive biologicals and peptides are shipped in validated insulated containers with real-time temperature data loggers to ensure uncompromised cold-chain integrity.
Accelerate your pharmaceutical development and secure reliable, SFDA-compliant API supply chains in Saudi Arabia today.
Send Inquiry Now